Visfatin: A New Adipokine

See allHide authors and affiliations

Science  21 Jan 2005:
Vol. 307, Issue 5708, pp. 366-367
DOI: 10.1126/science.1106933

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Too much abdominal (visceral) fat increases an individual's risk of developing insulin resistance and other metabolic disorders. In a Perspective, Hug and Lodish discuss the unexpected finding that blood levels of a hormone produced by visceral fat, called visfatin, correlate with obesity ( Fukuhara et al.). Surprisingly, visfatin has beneficial, insulin-like activity and is able to bind to the insulin receptor, lowering blood glucose levels. The implications of this finding for diabetes research and therapy are discussed by the Perspective authors.